+ New Watchlist

Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

Mycotopia Therapies

TPIAOTCPK

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$0.0167

At close: Dec 19, 1:07 PM EDT

$0.1300

0.11678.44%

After Hours: Mar 22, 9:26 AM EDT

Mycotopia Therapies (TPIA) Forecast

News

Earnings Mycotopia Therapies (TPIA) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for Mycotopia Therapies (OTC:TPIA) Stock

Mycotopia Therapies Stock (OTC: TPIA)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, May 25, 2022

Psyched: Medical Psychedelics In Davos, Canadian Sen Does Psychedelics, Ei.Ventures & Mycotopia To Merge Into $383M Company
Natan Ponieman

Monday, May 23, 2022

Ehave's Mycotopia Therapies To Merge With Ei.Ventures To Form PSLY.COM
Vuk Zdinjak

Friday, May 20, 2022

Ei.Ventures And Mycotopia To Merge Into New Psychedelic Mushroom Company
Natan Ponieman

Monday, March 21, 2022

Mycotopia Therapies Expands Supply Agreement With HAVN Life Sciences To Include Functional Mushrooms & Other Products
Jelena Martinovic

Friday, March 18, 2022

Psychedelic Medicine Is On The Rise - Only 5 Days Left To Invest In This Groundbreaking Company
Kevin Vandenboss - Sponsored

Tuesday, March 15, 2022

Could Mushrooms Treat Mental Health Disorders? This Company Thinks It Found the Key And Retail Investors Can Help
Kevin Vandenboss - Sponsored

Wednesday, December 08, 2021

Psychedelics Stock Mycotopia On The Move Following LOI To Merge With Ei.Ventures In $360M Transaction
Nina Zdinjak

Monday, August 30, 2021

Psyched: Cybin Gets $9 Price Target, FSD Pharma Acquires Lucid, New Trials From Psilera, Awakn, PharmaDrug And Braxia, California Bill Put On Hold
Natan Ponieman

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved